CXCR3, CXCL10 and type 1 diabetes

A Antonelli, SM Ferrari, A Corrado, E Ferrannini… - Cytokine & growth factor …, 2014 - Elsevier
Abstract Type 1 diabetes (T1D) is due to antigen-specific assaults on the insulin producing
pancreatic β-cells by diabetogenic T-helper (Th) 1 cells.(CXC motif) ligand (CXCL) 10, an …

Biomarkers of disease activity in multiple sclerosis

JJ Graber, S Dhib-Jalbut - Journal of the neurological sciences, 2011 - Elsevier
As therapeutic options for multiple sclerosis widen, validated biomarkers of clinical disease
activity are urgently needed. Reliable biomarkers would assist in choosing initial therapy …

Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma

C Karagiannidis, M Akdis, P Holopainen… - Journal of Allergy and …, 2004 - Elsevier
BACKGROUND: T regulatory (Treg) cells are characterized by expression of suppressive
cytokines and the transcription factor FOXP3. They play a key role in balancing immune …

Functional defect of regulatory CD4+CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis

A Balandina, S Lécart, P Dartevelle, A Saoudi… - Blood, 2005 - ashpublications.org
Abstract Thymus-derived CD4+ CD25+ regulatory T (Treg) cells are essential for the
maintenance of immunologic self-tolerance. Despite their critical role in the active …

Decreased FOXP3 levels in multiple sclerosis patients

J Huan, N Culbertson, L Spencer… - Journal of …, 2005 - Wiley Online Library
Autoimmune diseases such as multiple sclerosis (MS) may result from the failure of
tolerance mechanisms to prevent expansion of pathogenic T cells. Our study is the first to …

CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence

E Yurchenko, M Tritt, V Hay, EM Shevach… - The Journal of …, 2006 - rupress.org
Pathogen persistence after clinical cure is a hallmark of many chronic infections. Previously,
we showed that naturally occurring CD4+ CD25+ regulatory T (nTreg) cells rapidly …

[HTML][HTML] PRMT5-selective inhibitors suppress inflammatory T cell responses and experimental autoimmune encephalomyelitis

LM Webb, SA Amici, KA Jablonski… - The Journal of …, 2017 - journals.aai.org
In the autoimmune disease multiple sclerosis and its animal model, experimental
autoimmune encephalomyelitis (EAE), expansion of pathogenic, myelin-specific Th1 cell …

Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: An ex vivo and in vitro longitudinal study in relapsing− remitting multiple sclerosis

C de Andrés, C Aristimuño, V de Las Heras… - Journal of …, 2007 - Elsevier
Interferon beta-1a (IFNâ-1a) has demonstrated efficacy in multiple sclerosis (MS), although
its mechanism of action remains only partly understood. We evaluated the ex vivo and in …

Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis

M Bonelli, K von Dalwigk, A Savitskaya… - Annals of the …, 2008 - ard.bmj.com
Objectives: The forkhead family transcription factor Foxp3 currently represents the most
specific marker molecule for CD4+ CD25+ T cells with suppressive/regulatory capacity …

Pregnancy-induced expansion of regulatory T-lymphocytes may mediate protection to multiple sclerosis activity

S Sánchez-Ramón, J Navarroa, C Aristimuño… - Immunology letters, 2005 - Elsevier
Pregnancy represents a physiological transitory state of immune tolerance to avoid the
rejection of the foetus, and concomitantly of stabilisation of many autoimmune diseases …